SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

被引：20

作者：

de la Pena, Francisco Ayala ^{[1
]}

Novoa, Silvia Antolin ^{[2
]}

Gregori, Joaquin Gavila ^{[3
]}

Cortijo, Lucia Gonzalez ^{[4
]}

Carrasco, Fernando Henao ^{[5
]}

Martinez, Maria Teresa Martinez ^{[6
]}

Estevez, Cristina Morales ^{[7
]}

Stradella, Agostina ^{[8
]}

Losada, Maria Jesus Vidal ^{[9
]}

Ciruelos, Eva ^{[10
,11
]}

机构：

[1] Univ Murcia, Hosp G Univ Morales Meseguer, Dept Med Oncol, Ave Marques Velez S-N, Murcia 30008, Spain

[2] CHUAC, Dept Med Oncol, Coruna, Spain

[3] Fdn Inst Valenciano Oncol IVO, Valencia, Spain

[4] Hosp Univ Quironsalud, Med Oncol Dept, Madrid, Spain

[5] Hosp Univ Virgen Macarena, Seville, Spain

[6] Univ Valencia, Hosp Clin Valencia, INCLIVA Biomed Res Inst, Med Oncol Dept, Valencia 46010, Spain

[7] Hosp Univ Reina Sofia, Cordoba, Spain

[8] Inst Catala Oncol, Med Oncol Dept, Lhospitalet De Llobregat, Barcelona, Spain

[9] Hosp Clin Barcelona, Barcelona, Spain

[10] Univ Hosp 12 Octubre, Med Oncol Dept, Breast Canc Unit, Madrid, Spain

[11] HM Hosp, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2023年 / 25卷 / 09期

关键词：

Early breast cancer; Adjuvant; Neoadjuvant; Follow-up; OPEN-LABEL; FOLLOW-UP; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; DISTANT RECURRENCE; DOUBLE-BLIND; NEOADJUVANT TREATMENT; AROMATASE INHIBITORS; TREATMENT DECISIONS; 70-GENE SIGNATURE;

D O I：

10.1007/s12094-023-03215-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is rapidly increasing. Thanks to the screening programs in place, nearly 90% of breast cancer cases are detected in early and potentially curable stages, despite the COVID-19 pandemic possibly having impacted these numbers (not yet quantified). In recent years, locoregional and systemic therapies are increasingly being directed by new diagnostic tools that have improved the balance between toxicity and clinical benefit. New therapeutic strategies, such as immunotherapy, targeted drugs, and antibody-drug conjugates have also improved outcomes in some patient subgroups. This clinical practice guideline is based on a systematic review of relevant studies and on the consensus of experts from GEICAM, SOLTI, and SEOM.

引用

页码：2647 / 2664

页数：18

共 113 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI [DOI 10.1016/S0140-6736(05)66544-0, 10.1016/s0140-6736(05)66544-0]

[2] Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study [J].

Alba, E. ;

Calvo, L. ;

Albanell, J. ;

De la Haba, J. R. ;

Arcusa Lanza, A. ;

Chacon, J. I. ;

Sanchez-Rovira, P. ;

Plazaola, A. ;

Lopez Garcia-Asenjo, J. A. ;

Bermejo, B. ;

Carrasco, E. ;

Lluch, A. .

ANNALS OF ONCOLOGY, 2012, 23 (12) :3069-3074

[3] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[4] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial [J].

Albain, Kathy S. ;

Barlow, William E. ;

Shak, Steven ;

Hortobagyi, Gabriel N. ;

Livingston, Robert B. ;

Yeh, I-Tien ;

Ravdin, Peter ;

Bugarini, Roberto ;

Boehner, Frederick L. ;

Davidson, Nancy E. ;

Sledge, George W. ;

Winer, Eric P. ;

Hudis, Clifford ;

Ingle, James N. ;

Perez, Edith A. ;

Pritchard, Kathleen I. ;

Shepherd, Lois ;

Gralow, Julie R. ;

Yoshizawa, Carl ;

Allred, D. Craig ;

Osborne, C. Kent ;

Hayes, Daniel F. .

LANCET ONCOLOGY, 2010, 11 (01) :55-65

[5] Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update [J].

Allison, Kimberly H. ;

Hammond, M. Elizabeth H. ;

Dowsett, Mitchell ;

McKernin, Shannon E. ;

Carey, Lisa A. ;

Fitzgibbons, Patrick L. ;

Hayes, Daniel F. ;

Lakhani, Sunil R. ;

Chavez-MacGregor, Mariana ;

Perlmutter, Jane ;

Perou, Charles M. ;

Regan, Meredith M. ;

Rimm, David L. ;

Symmans, W. Fraser ;

Torlakovic, Emina E. ;

Varella, Leticia ;

Viale, Giuseppe ;

Weisberg, Tracey F. ;

McShane, Lisa M. ;

Wolff, Antonio C. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) :1346-+

[6] Adjuvant chemotherapy for small, lymph node-negative, triple-negative breast cancer: A single-center study and a meta-analysis of the published literature [J].

An, Xin ;

Lei, Xuefen ;

Huang, Riqing ;

Luo, Rongzhen ;

Li, Haifeng ;

Xu, Fei ;

Yuan, Zhongyu ;

Wang, Shusen ;

de Nonneville, Alexandre ;

Goncalves, Anthony ;

Houvenaeghel, Gilles ;

Li, Jibin ;

Xue, Cong ;

Shi, Yanxia .

CANCER, 2020, 126 :3837-3846

[7] Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update [J].

Andre, Fabrice ;

Ismaila, Nofisat ;

Allison, Kimberly H. ;

Barlow, William E. ;

Collyar, Deborah E. ;

Damodaran, Senthil ;

Henry, N. Lynn ;

Jhaveri, Komal ;

Kalinsky, Kevin ;

Kuderer, Nicole M. ;

Litvak, Anya ;

Mayer, Erica L. ;

Pusztai, Lajos ;

Raab, Rachel ;

Wolff, Antonio C. ;

Stearns, Vered .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) :1816-+

[8]

[Anonymous], 2013, J CLIN ONCOL, V31, P5

[9] St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment [J].

Balic, Marija ;

Thomssen, Christoph ;

Wuerstlein, Rachel ;

Gnant, Michael ;

Harbeck, Nadia .

BREAST CARE, 2019, 14 (02) :103-110

[10] Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study [J].

Banys-Paluchowski, Maggie ;

Gasparri, Maria Luisa ;

de Boniface, Jana ;

Gentilini, Oreste ;

Stickeler, Elmar ;

Hartmann, Steffi ;

Thill, Marc ;

Rubio, Isabel T. ;

Di Micco, Rosa ;

Bonci, Eduard-Alexandru ;

Niinikoski, Laura ;

Kontos, Michalis ;

Karadeniz Cakmak, Guldeniz ;

Hauptmann, Michael ;

Peintinger, Florentia ;

Pinto, David ;

Matrai, Zoltan ;

Murawa, Dawid ;

Kadayaprath, Geeta ;

Dostalek, Lukas ;

Nina, Helidon ;

Krivorotko, Petr ;

Classe, Jean-Marc ;

Schlichting, Ellen ;

Appelgren, Matilda ;

Paluchowski, Peter ;

Solbach, Christine ;

Blohmer, Jens-Uwe ;

Kuehn, Thorsten .

CANCERS, 2021, 13 (07)

← 1 2 3 4 5 6 7 8 9 10 →